Speciality Formulations Private Limited
About Speciality Formulations Private Limited
Data last updated:
Speciality Formulations Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 21 August 1965 and has been in existence for over 61 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33112MH1965PTC013298. Its GSTIN is 27AAACS9133P1ZT (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors Ulka Deepu Kishinchandani and Pratipada Sanjay Sapre.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.7 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹39.57 Lakh (net margin 133.3%) and EBITDA of ₹30.98 Lakh (EBITDA margin 104.3%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Speciality Formulations has one previous CIN (Corporate Identification Number): U33112MH2004PTC013298. The current CIN is U33112MH1965PTC013298, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33112MH1965PTC013298 | Current |
| U33112MH2004PTC013298 | Previous |
Contact details
Speciality Formulations Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address41/A 4th Floor 46 Embassy Apartment Laxmibai Jagmohandas Marg Nepean Sea Road A.K., Marg, Mumbai, Maharashtra, India – 400036
- IndustryReal Estate, Real Estate Leasing
To see the full contact details of Speciality Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Speciality Formulations Private Limited
FY 2025 filings availableSpeciality Formulations Private Limited reported revenue of ₹29.7 Lakh (down 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 27% fall in the latest year. EBITDA fell 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 104.3% | ||||
| Net Profit Margin | 133.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Speciality Formulations Private Limited, buy the company report.
Board of directors of Speciality Formulations Private Limited
Speciality Formulations has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ulka Deepu Kishinchandani | Director | 01 Jan 1983 | 43 Years 9 Months | Current |
| Pratipada Sanjay Sapre | Director | 22 Dec 2017 | 8 Years 10 Months | Current |
Auditor
Speciality Formulations Private Limited is audited by RAJENDRA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJENDRA & CO. | FY 2017 | 108355W |
Shareholding
The shareholding of Speciality Formulations Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Speciality Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Speciality Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Speciality Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Speciality Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACS9133P1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Speciality Formulations Private Limited, buy the company report.
Recent activity
Speciality Formulations Private Limited has 5 board changes on record since 1983: 2 appointments and 3 cessations. The latest: Kunda Vishwanath Sapre ceased to be Director on 02 Jan 2020.
Frequently asked questions
Speciality Formulations is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 21 August 1965 (61+ years old) and is registered under CIN U33112MH1965PTC013298.
Speciality Formulations has 2 current directors:
- Ulka Deepu Kishinchandani - Director
- Pratipada Sanjay Sapre - Director
The latest financial statements of Speciality Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Speciality Formulations is 27AAACS9133P1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Speciality Formulations is U33112MH1965PTC013298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Speciality Formulations was incorporated on 21 August 1965, making it 61+ years old. It is registered with the Registrar of Companies, Mumbai.
Kunda Vishwanath Sapre ceased to be Director on 02 Jan 2020. Pratipada Sanjay Sapre ceased to be Additional Director on 30 Sep 2018. Pratipada Sanjay Sapre was appointed as Director on 22 Dec 2017. Speciality Formulations has 5 board changes on record in total.
The registered office of Speciality Formulations is at 41A 4th Floor 46 Embassy Apartment Laxmibai Jagmohandas Marg Nepean Sea Road A.K., Marg, Mumbai, Maharashtra, India – 400036.
Speciality Formulations operates in the real estate industry, in the real estate leasing segment.
The compliance status of Speciality Formulations is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.